Maine Code § 24-A-4256

Coverage for medically necessary infant formula
Open in Lexace · Ask the AI about this section
(REALLOCATED FROM TITLE 24-A, SECTION 4254)
All individual and group health maintenance organization policies, contracts and certificates must
provide coverage for amino acid-based elemental infant formula for children 2 years of age and under
in accordance with this section. [PL 2007, c. 695, Pt. C, §16 (RAL).]
1. Determination of medical necessity. Coverage for amino acid-based elemental infant formula
must be provided when a licensed physician has submitted documentation that the amino acid-based
elemental infant formula is medically necessary health care as defined in section 4301-A, subsection
10-A, that the amino acid-based elemental infant formula is the predominant source of nutritional intake
at a rate of 50% or greater and that other commercial infant formulas, including cow milk-based and
soy milk-based formulas have been tried and have failed or are contraindicated. A licensed physician
may be required to confirm and document ongoing medical necessity at least annually.
[PL 2007, c. 695, Pt. C, §16 (RAL).]
2. Method of delivery. Coverage for amino acid-based elemental infant formula must be provided
without regard to the method of delivery of the formula.
[PL 2007, c. 695, Pt. C, §16 (RAL).]
3. Required diagnosis. Coverage for amino acid-based elemental infant formula must be provided
when a licensed physician has diagnosed and through medical evaluation has documented one of the
following conditions:
A. Symptomatic allergic colitis or proctitis; [PL 2007, c. 695, Pt. C, §16 (RAL).]
B. Laboratory- or biopsy-proven allergic or eosinophilic gastroenteritis; [PL 2007, c. 695, Pt.
C, §16 (RAL).]
C. A history of anaphylaxis; [PL 2007, c. 695, Pt. C, §16 (RAL).]
D. Gastroesophageal reflux disease that is nonresponsive to standard medical therapies; [PL 2007,
c. 695, Pt. C, §16 (RAL).]
E. Severe vomiting or diarrhea resulting in clinically significant dehydration requiring treatment
by a medical provider; [PL 2007, c. 695, Pt. C, §16 (RAL).]
F. Cystic fibrosis; or [PL 2007, c. 695, Pt. C, §16 (RAL).]
G. Malabsorption of cow milk-based or soy milk-based infant formula. [PL 2007, c. 695, Pt. C,
§16 (RAL).]
[PL 2007, c. 695, Pt. C, §16 (RAL).]

4. Health savings accounts. Coverage for amino acid-based elemental infant formula under a
health insurance policy, contract or certificate issued in connection with a health savings account as
authorized under Title XII of the federal Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 may be subject to the same deductible and out-of-pocket limits that apply to overall benefits
under the policy, contract or certificate.
[PL 2007, c. 695, Pt. C, §16 (RAL).]

‹ Prev All Maine sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.